Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Class Switching | 10 | 2023 | 19 | 2.860 |
Why?
|
| Cytidine Deaminase | 10 | 2023 | 34 | 2.710 |
Why?
|
| B-Lymphocytes | 9 | 2021 | 185 | 1.980 |
Why?
|
| Germinal Center | 4 | 2021 | 10 | 1.880 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 5 | 2023 | 8 | 1.830 |
Why?
|
| Recombination, Genetic | 4 | 2021 | 93 | 1.330 |
Why?
|
| DNA Mismatch Repair | 2 | 2023 | 25 | 0.910 |
Why?
|
| Immunoglobulin Heavy Chains | 4 | 2023 | 62 | 0.900 |
Why?
|
| Ataxia Telangiectasia | 1 | 2023 | 6 | 0.890 |
Why?
|
| Introns | 3 | 2023 | 75 | 0.850 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 18 | 0.800 |
Why?
|
| Peyer's Patches | 2 | 2021 | 16 | 0.800 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2022 | 61 | 0.790 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2021 | 42 | 0.780 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 23 | 0.770 |
Why?
|
| Cell Communication | 1 | 2021 | 97 | 0.750 |
Why?
|
| DNA Breaks, Double-Stranded | 6 | 2023 | 35 | 0.720 |
Why?
|
| Algorithms | 1 | 2022 | 465 | 0.660 |
Why?
|
| Cell Differentiation | 2 | 2021 | 587 | 0.650 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 2019 | 16 | 0.640 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 539 | 0.640 |
Why?
|
| Mice | 15 | 2023 | 5913 | 0.580 |
Why?
|
| DNA | 3 | 2023 | 574 | 0.550 |
Why?
|
| Animals | 20 | 2023 | 15081 | 0.530 |
Why?
|
| DNA Repair | 5 | 2023 | 188 | 0.470 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 31 | 0.460 |
Why?
|
| Mice, Knockout | 5 | 2023 | 933 | 0.400 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2023 | 31 | 0.400 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2012 | 173 | 0.400 |
Why?
|
| Phosphorylation | 7 | 2019 | 928 | 0.350 |
Why?
|
| Replication Protein A | 1 | 2009 | 8 | 0.340 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 73 | 0.320 |
Why?
|
| Protein Binding | 6 | 2018 | 972 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2004 | 187 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1609 | 0.260 |
Why?
|
| Microtubule-Organizing Center | 1 | 2004 | 2 | 0.250 |
Why?
|
| Repressor Proteins | 2 | 2004 | 249 | 0.250 |
Why?
|
| Humans | 17 | 2023 | 37093 | 0.240 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2004 | 114 | 0.230 |
Why?
|
| Hepatitis B | 1 | 2023 | 38 | 0.230 |
Why?
|
| Parity | 1 | 2022 | 46 | 0.210 |
Why?
|
| Feedback | 1 | 2022 | 53 | 0.200 |
Why?
|
| Sequence Homology | 1 | 2021 | 34 | 0.200 |
Why?
|
| Serine | 2 | 2013 | 75 | 0.200 |
Why?
|
| Uracil-DNA Glycosidase | 1 | 2019 | 4 | 0.180 |
Why?
|
| Genes, Immunoglobulin | 1 | 2019 | 41 | 0.180 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 1180 | 0.170 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2018 | 2 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 409 | 0.160 |
Why?
|
| Female | 3 | 2022 | 20969 | 0.150 |
Why?
|
| Pregnancy | 1 | 2022 | 1549 | 0.140 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 357 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2002 | 239 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 43 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 219 | 0.110 |
Why?
|
| Deamination | 1 | 2012 | 2 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 1103 | 0.110 |
Why?
|
| Male | 3 | 2021 | 20025 | 0.110 |
Why?
|
| Spermatogenesis | 1 | 2013 | 155 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 80 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 168 | 0.100 |
Why?
|
| Cell Line | 5 | 2004 | 1354 | 0.090 |
Why?
|
| Retroviridae Infections | 1 | 2009 | 3 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2013 | 681 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1015 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2004 | 6 | 0.080 |
Why?
|
| Janus Kinase 1 | 2 | 2004 | 18 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2013 | 1908 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 295 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2004 | 132 | 0.070 |
Why?
|
| Cell Fractionation | 1 | 2004 | 30 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2019 | 1518 | 0.060 |
Why?
|
| Centrosome | 1 | 2004 | 28 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 77 | 0.060 |
Why?
|
| Interleukin-4 | 2 | 2002 | 72 | 0.060 |
Why?
|
| Mutation | 1 | 2009 | 1095 | 0.060 |
Why?
|
| Hepatitis B virus | 1 | 2023 | 13 | 0.060 |
Why?
|
| Macaca fascicularis | 1 | 2023 | 64 | 0.060 |
Why?
|
| Microtubules | 1 | 2004 | 120 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 408 | 0.060 |
Why?
|
| France | 1 | 2022 | 17 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2002 | 8 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2002 | 46 | 0.050 |
Why?
|
| Interferon-gamma | 1 | 2023 | 250 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2023 | 157 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 117 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2018 | 1198 | 0.050 |
Why?
|
| Receptor, Insulin | 1 | 2001 | 25 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 689 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2002 | 305 | 0.040 |
Why?
|
| DNA Damage | 1 | 2002 | 352 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2001 | 163 | 0.040 |
Why?
|
| Receptors, Complement 3d | 1 | 2019 | 3 | 0.040 |
Why?
|
| Pentosyltransferases | 1 | 1999 | 4 | 0.040 |
Why?
|
| Geobacillus stearothermophilus | 1 | 1999 | 10 | 0.040 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2018 | 3 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2015 | 236 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 173 | 0.040 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1997 | 3 | 0.040 |
Why?
|
| Nucleocapsid | 1 | 1997 | 12 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1371 | 0.040 |
Why?
|
| Capsid | 1 | 1997 | 54 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1997 | 183 | 0.040 |
Why?
|
| G-Quadruplexes | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 33 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2015 | 119 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2015 | 29 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 2002 | 325 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2013 | 29 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 661 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2013 | 45 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 196 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 2 | 2002 | 4 | 0.030 |
Why?
|
| Drosophila | 1 | 2013 | 144 | 0.030 |
Why?
|
| Chromatin | 1 | 2013 | 169 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2002 | 50 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2015 | 325 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2013 | 272 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 571 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 286 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 14 | 0.020 |
Why?
|
| Exons | 1 | 2009 | 88 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 131 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 286 | 0.020 |
Why?
|
| Crystallization | 2 | 1999 | 86 | 0.020 |
Why?
|
| Crystallography, X-Ray | 2 | 1999 | 265 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 448 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 997 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1568 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2002 | 35 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2002 | 109 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 52 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 2002 | 16 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 57 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 63 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 88 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 191 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 81 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fes | 1 | 2001 | 3 | 0.010 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 9 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 246 | 0.010 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2001 | 20 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2002 | 174 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 523 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 188 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 307 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 444 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 502 | 0.010 |
Why?
|
| Pseudouridine | 1 | 1999 | 6 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2001 | 269 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 112 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 96 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 269 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 389 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1207 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 1742 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 433 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 515 | 0.010 |
Why?
|
| Gene Expression | 1 | 1999 | 674 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1997 | 453 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1997 | 808 | 0.010 |
Why?
|